Early research (Phase 1)Study completedNCT05585398
What this trial is testing
Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods
Who this might be right for
N/A, as no Specific Medical Condition Will be Treated
Merz Pharmaceuticals GmbH 40